VENUS MEDTECH-B(02500): Cardiovalve Ltd. and MTH IP, L.P. filed a patent infringement lawsuit against Edwards for US Patent No. 385.

date
12:13 22/01/2026
avatar
GMT Eight
Qi Ming Medical - B (02500) announced on June 9, 2025 that the United States Federal Circuit Court of Appeals has ruled to confirm the validity of certain patent claims of the US Patent No. 10,702,385 (Implantable Heart Valve) owned by Cardiovalve Ltd. (referred to as the 385th Patent), while Edwards Lifesciences Corp. and Edwards Lifesciences LLC (referred to as "Edwards") had raised objections to the patent during a dual review process in June 2021.
VENUS MEDTECH-B (02500) announces that on June 9, 2025, the United States Federal Circuit Court of Appeals ruled to confirm the validity of certain claims of US Patent No. 10,702,385 (Heart Valve Implant) held by Cardiovalve Ltd. (the '385 Patent), while Edwards Lifesciences Corp. and Edwards Lifesciences LLC (collectively "Edwards") had challenged the patent in a review process in June 2021. On January 14, 2026, Cardiovalve Ltd. and MTH IP, L.P. filed a patent infringement lawsuit against Edwards in the District Court of Delaware relating to the '385 Patent, alleging that Edwards' core product PASCAL Precision valve repair system infringes the '385 Patent owned by Cardiovalve Ltd. As the lawsuit is still in its preliminary stages, further details (including potential claims amounts) will depend on the outcome of the litigation. The company will make further announcements in accordance with the listing rules of the Hong Kong Stock Exchange at the appropriate time regarding any material developments in the lawsuit.